Avidity Biosciences, Inc.
Key Metrics
Market Snapshot
About
Avidity Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs). The company combines the targeting ability of monoclonal antibodies with the precision of oligonucleotide therapies to address genetic diseases affecting muscle and other tissues. Avidity is advancing multiple programs for rare genetic diseases.